Vasant Nagvekar

409 total citations
15 papers, 178 citations indexed

About

Vasant Nagvekar is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, Vasant Nagvekar has authored 15 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Molecular Medicine and 5 papers in Epidemiology. Recurrent topics in Vasant Nagvekar's work include Antibiotic Resistance in Bacteria (6 papers), Antibiotic Use and Resistance (5 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Vasant Nagvekar is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antibiotic Use and Resistance (5 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Vasant Nagvekar collaborates with scholars based in India, Belgium and United Kingdom. Vasant Nagvekar's co-authors include Sheetal Sawant, Balaji Veeraraghavan, Anup Warrier, Rishi Jain, Atul P Kulkarni, Ashish Agrawal, Raunak Parikh, Alberta Di Pasquale, Jacob John and Ankur Mutreja and has published in prestigious journals such as SHILAP Revista de lepidopterología, Genomics and Diagnostic Microbiology and Infectious Disease.

In The Last Decade

Vasant Nagvekar

12 papers receiving 173 citations

Peers

Vasant Nagvekar
Naomi M. Fuller United Kingdom
Helmia Farida Indonesia
Norazah Ahmad Malaysia
Thanh Le-Viet United Kingdom
Vasant Nagvekar
Citations per year, relative to Vasant Nagvekar Vasant Nagvekar (= 1×) peers Nabeela Al‐Abdullah

Countries citing papers authored by Vasant Nagvekar

Since Specialization
Citations

This map shows the geographic impact of Vasant Nagvekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasant Nagvekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasant Nagvekar more than expected).

Fields of papers citing papers by Vasant Nagvekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasant Nagvekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasant Nagvekar. The network helps show where Vasant Nagvekar may publish in the future.

Co-authorship network of co-authors of Vasant Nagvekar

This figure shows the co-authorship network connecting the top 25 collaborators of Vasant Nagvekar. A scholar is included among the top collaborators of Vasant Nagvekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasant Nagvekar. Vasant Nagvekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bakthavatchalam, Yamuna Devi, Chaitra Shankar, Purva Mathur, et al.. (2024). In vitro activity of zidebactam/cefepime (WCK 5222), a β-lactam enhancer/ β-lactam combination against carbapenem- and colistin-resistant Klebsiella pneumoniae isolates. Diagnostic Microbiology and Infectious Disease. 111(1). 116561–116561.
2.
Mehta, Yatin, et al.. (2022). Prescription-Event Monitoring Study on Safety and Efficacy of Levonadifloxacin (Oral and I.V.) in Management of Bacterial Infections. International Journal of Applied and Basic Medical Research. 12(1). 30–36. 4 indexed citations
3.
Varughese, Santosh, et al.. (2022). Evaluation and Management of Tuberculosis in Solid Organ Transplant Recipients. SHILAP Revista de lepidopterología. 16(Suppl 1). S15–S22. 3 indexed citations
4.
Nagvekar, Vasant, et al.. (2021). Clinical Outcome of Patients on Ceftazidime–Avibactam and Combination Therapy in Carbapenem-resistant Enterobacteriaceae. Indian Journal of Critical Care Medicine. 25(7). 780–784. 20 indexed citations
5.
Jacob, Jobin John, Agila Kumari Pragasam, Karthick Vasudevan, et al.. (2021). Salmonella Typhi acquires diverse plasmids from other Enterobacteriaceae to develop cephalosporin resistance. Genomics. 113(4). 2171–2176. 21 indexed citations
7.
Nagvekar, Vasant, et al.. (2020). Prevalence of multidrug-resistant Gram-negative bacteria cases at admission in a multispeciality hospital. Journal of Global Antimicrobial Resistance. 22. 457–461. 32 indexed citations
8.
Agrawal, Ashish, et al.. (2019). Towards adult vaccination in India: a narrative literature review. Human Vaccines & Immunotherapeutics. 16(4). 991–1001. 29 indexed citations
9.
Kulkarni, Atul P, et al.. (2019). Current Perspectives on Treatment of Gram-Positive Infections in India: What Is the Way Forward?. Interdisciplinary Perspectives on Infectious Diseases. 2019. 1–8. 37 indexed citations
10.
Nagvekar, Vasant, et al.. (2018). Fatal Aspergillosis of the Renal Vasculature in a Combined Liver-Kidney Transplant Recipient. Indian Journal of Medical Microbiology. 36(3). 444–446. 1 indexed citations
12.
Nagvekar, Vasant, et al.. (2017). Mycobacterium abscessus causing native valve endocarditis due to peripherally inserted central catheter line. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 9. 19–20. 6 indexed citations
13.
Nagvekar, Vasant, et al.. (2016). High degree atrioventricular block with ventricular asystole in a case of dengue fever. Indian Heart Journal. 68. S194–S197. 8 indexed citations
14.
Ghafur, Abdul, et al.. (2012). “Save Antibiotics, Save lives”: an Indian success story of infection control through persuasive diplomacy. Antimicrobial Resistance and Infection Control. 1(1). 29–29. 12 indexed citations
15.
Nagvekar, Vasant, et al.. (2011). Hand hygiene compliance in India. BMC Proceedings. 5(S6). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026